日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Escherichia coli O9:H4 Chorismate synthase (aroC) CSB-YP424146EJF
CSB-EP424146EJF
CSB-BP424146EJF
CSB-MP424146EJF
CSB-EP424146EJF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O9:H4 Manganese transport protein MntH (mntH), partial CSB-YP424147EJF
CSB-EP424147EJF
CSB-BP424147EJF
CSB-MP424147EJF
CSB-EP424147EJF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O9:H4 Dihydrodipicolinate synthase (dapA) CSB-YP424148EJF
CSB-EP424148EJF
CSB-BP424148EJF
CSB-MP424148EJF
CSB-EP424148EJF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O9:H4 GTPase Der (der) CSB-YP424149EJF
CSB-EP424149EJF
CSB-BP424149EJF
CSB-MP424149EJF
CSB-EP424149EJF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O9:H4 Co-chaperone protein hscB (hscB) CSB-YP424150EJF
CSB-EP424150EJF
CSB-BP424150EJF
CSB-MP424150EJF
CSB-EP424150EJF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O9:H4 Cysteine/O-acetylserine efflux protein (eamB), partial CSB-YP424151EJF1
CSB-EP424151EJF1
CSB-BP424151EJF1
CSB-MP424151EJF1
CSB-EP424151EJF1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O9:H4 Probable inorganic polyphosphate/ATP-NAD kinase (ppnK) CSB-YP424152EJF
CSB-EP424152EJF
CSB-BP424152EJF
CSB-MP424152EJF
CSB-EP424152EJF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O9:H4 Alanine--tRNA ligase (alaS), partial CSB-YP424153EJF
CSB-EP424153EJF
CSB-BP424153EJF
CSB-MP424153EJF
CSB-EP424153EJF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O9:H4 5'/3'-nucleotidase SurE (surE) CSB-YP424154EJF
CSB-EP424154EJF
CSB-BP424154EJF
CSB-MP424154EJF
CSB-EP424154EJF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O9:H4 Sulfate adenylyltransferase subunit 1 (cysN) CSB-YP424155EJF
CSB-EP424155EJF
CSB-BP424155EJF
CSB-MP424155EJF
CSB-EP424155EJF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O9:H4 L-fucose mutarotase (fucU) CSB-YP424156EJF
CSB-EP424156EJF
CSB-BP424156EJF
CSB-MP424156EJF
CSB-EP424156EJF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O9:H4 4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase (kduI) CSB-YP424157EJF
CSB-EP424157EJF
CSB-BP424157EJF
CSB-MP424157EJF
CSB-EP424157EJF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O9:H4 S-adenosylmethionine synthase (metK) CSB-YP424158EJF
CSB-EP424158EJF
CSB-BP424158EJF
CSB-MP424158EJF
CSB-EP424158EJF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O9:H4 3,4-dihydroxy-2-butanone 4-phosphate synthase (ribB) CSB-YP424159EJF
CSB-EP424159EJF
CSB-BP424159EJF
CSB-MP424159EJF
CSB-EP424159EJF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O9:H4 Putrescine aminotransferase (patA) CSB-YP424160EJF
CSB-EP424160EJF
CSB-BP424160EJF
CSB-MP424160EJF
CSB-EP424160EJF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O9:H4 DnaA initiator-associating protein diaA (diaA) CSB-YP424161EJF
CSB-EP424161EJF
CSB-BP424161EJF
CSB-MP424161EJF
CSB-EP424161EJF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O9:H4 Ribosome-binding factor A (rbfA) CSB-YP424162EJF
CSB-EP424162EJF
CSB-BP424162EJF
CSB-MP424162EJF
CSB-EP424162EJF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O9:H4 50S ribosomal protein L27 (rpmA) CSB-YP424163EJF
CSB-EP424163EJF
CSB-BP424163EJF
CSB-MP424163EJF
CSB-EP424163EJF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O9:H4 Putative sialic acid transporter (nanT), partial CSB-YP424164EJF
CSB-EP424164EJF
CSB-BP424164EJF
CSB-MP424164EJF
CSB-EP424164EJF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O9:H4 Shikimate dehydrogenase (aroE) CSB-YP424165EJF
CSB-EP424165EJF
CSB-BP424165EJF
CSB-MP424165EJF
CSB-EP424165EJF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×